NEWS
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Just Updated: Compare Your Institution (Live Data)
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025 (Updated Today)
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
For Students
local_fire_department
Country Reports
person
Find a Professional
Thomas J Kipps
University of California San Diego - San Diego / United States
Medical and Health Sciences / Hematology
AD Scientific Index ID: 1771450
Registration, Add Profile,
Premium Membership
Get Your Global Impact Certificate
Ranking &
Analysis
Job
Experiences
Education
Information
Published Books
Book Chapters
Articles
Presentations
Lessons
Projects
Co-Authors
Subject Leaders
Editorship, Referee &
Scientific Board
Patents /
Designs
Academic Grants
& Awards
Artistic
Activities
Certificate / Course
/ Trainings
Association &
Society Memberships
Contact, Office
& Social Media
person_outline
Thomas J Kipps's MOST POPULAR ARTICLES
1-)
Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia Proceedings of the national academy of sciences 99 (24), 15524-15529, 2002
2-)
miR-15 and miR-16 induce apoptosis by targeting BCL2 Proceedings of the National Academy of Sciences 102 (39), 13944-13949, 2005
3-)
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National … Blood, The Journal of the American Society of Hematology 111 (12), 5446-5456, 2008
4-)
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia New England Journal of Medicine 353 (17), 1793-1801, 2005
5-)
Idelalisib and rituximab in relapsed chronic lymphocytic leukemia New England Journal of Medicine 370 (11), 997-1007, 2014
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept